TriSalus Life Sciences TLSI Q1 2026 Earnings EPS Surges Past Expectations Yet Stock Slips UTSI Q4 2019 Earnings Significant EPS Miss Highlights Operational Challenges BMA Q4 2025 Earnings Strong EPS Beat Amidst Mixed Market Reaction Cytek Biosciences Q1 2026 Earnings Deep EPS Miss Fails to Dampen Investor Sentiment BNTX Q1 2026 Earnings NarrowerThanExpected Loss as BioNTech Focuses on Pipeline Progress CPHC Q2 2025 Earnings Narrow Loss and Modest Stock Gain Amid Quiet Quarter